Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz

OZDEK, SENGÜL; OZDEMIR ZEYDANLI, ECE

doi:10.37783/CRJ-0358

Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz

Şengül ÖZDEK, (Gazi Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye)

Ece ÖZDEMİR ZEYDANLI (Gazi Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye)

Güncel Retina Dergisi

3 0

Yıl: 2023 Cilt: 7 Sayı: 3 Sayfa Aralığı: 174 - 180 Metin Dili: Türkçe DOI: 10.37783/CRJ-0358 İndeks Tarihi: 27-07-2023

Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz

Öz:

Persistan fetal damar (PFV) sendromu, fetal hyaloid sistem kalıntılarını değişken derecelerde içeren ve gözün hemen hemen tüm kısımlarını etkileyen gelişimsel bir anomalidir. PFV sendromu uzun yıllardır bilinmesine rağmen, hastalık ile ilişkili bulguların spektrumu halen tam olarak anlaşılamamıştır. Bu heterojen ve geniş spektrum, hastalığın tanı ve tedavisini zorlaştırmaktadır. Bu derleme ile, PFV’nin klinik özelliklerinin ve ilişkili anatomik varyasyonların, cerrahi endikasyonlar ve tekniklerin ve hastalık prognozunun güncel literatür ve klinik deneyimimiz ışığında gözden geçirilmesi hedeflenmiştir.

Anahtar Kelime:

Persistent Fetal Vasculature Syndrome: Pathogenesis, Diagnosis, Treatment, and Prognosis

Öz:

Persistent fetal vasculature (PFV) is a developmental disease that involves varying degrees of fetal hyaloid system remnants and affects almost all parts of the eye. Although PFV syndrome has been known for many years, the full spectrum of findings is still not fully understood and the disease continues to present with surprises. This heterogeneous spectrum makes the diagnosis and the management challenging . The aim of this review is to present clinical features and anatomical variations, surgical indications and techniques, and the prognosis of PFV in light of current literature and our clinical experience.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Bibliyografik

1. Goldberg MF. Persistent fetal vasculature (PFV): An integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV) LIV Edward Jackson Memorial Lecture. In: American Journal of Ophthalmology. Vol 124. ; 1997:587-626.
2. Levine RA, Gray DL, Gould N, Pergament E, Stillerman ML. Warburg Syndrome. Ophthalmology. 1983;90(12):1600- 1603.
3. Marshman WE, Jan JE, Lyons CJ. Neurologic abnormalities associated with persistent hyperplastic primary vitreous. Can J Ophthalmol. 1999;34(1):17-22.
4. Haddad R, Font RL, Reeser F. Persistent hyperplastic primary vitreous. A clinicopathologic study of 62 cases and review of the literature. Surv Ophthalmol. 1978;23(2):123-134.
5. Chen C, Xiao H, Ding X. Persistent Fetal Vasculature. Asia-Pacific J Ophthalmol (Philadelphia, Pa). 2019;8(1):86- 95.
6. Galal AH, Kotoury AIS, Azzab AA. Bilateral persistent hyperplastic primary vitreous: An Egyptian family supporting a rare autosomal dominant inheritance. Genet Couns. 2006;17(4):441-447.
7. Khaliq S, Hameed A, Ismail M, Anwar K, Leroy B, Payne AM, et al. Locus for autosomal recessive nonsyndromic persistent hyperplastic primary vitreous. Investig Ophthalmol Vis Sci. 2001;42(10):2225-2228.
8. Mutlu F, Leopold IH. The Structure of Fetal Hyaloid System and Tunica Vasculosa Lentis. Arch Ophthalmol. 1964;71(1):102-110.
9. Sellheyer K, Spitznas M. Ultrastructure of the human posterior tunica vasculosa lentis during early gestation. Graefe’s Arch Clin Exp Ophthalmol. 1987;225(5):377-383.
10. Barishak YR. Embryology of the eye and its adnexae. Dev Ophthalmol. 1992;24:1-142.
11. Meisels HI, Goldberg MF. Vascular anastomoses between the iris and persistent hyperplastic primary vitreous. Am J Ophthalmol. 1979;88(2): 179-181.
12. Zhang C, Asnaghi L, Gongora C, Patek B, Hose S, Ma B, et al. A developmental defect in astrocytes inhibits programmed regression of the hyaloid vasculature in the mammalian eye. Eur J Cell Biol. 2011;90(5):440-448.
13. Zigler JS, Valapala M, Shang P, Hose S, Goldberg MF, Sinha D. βa3/A1-crystallin and persistent fetal vasculature (PFV) disease of the eye. Biochim Biophys Acta - Gen Subj. 2016;1860(1):287-298.
14. Martin AC, Thornton JD, Liu J, Wang X, Zuo J, Jablonski MM, et al. Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the Arf tumor suppressor gene. Investig Ophthalmol Vis Sci. 2004;45(10):3387-3396.
15. Ozdek S, Ozdemir Zeydanli E, Atalay HT, Aktas Z. Anterior elongation of the retina in persistent fetal vasculature: emphasis on retinal complications. Eye. 2019;33(6):938-947.
16. Federman JL, Shields JA, Altman B, Koller H. The Surgical and Nonsurgical Management of Persistent Hyperplastic Prima Vitreous. Ophthalmology. 1982;89(1):20-24.
17. Karacorlu M, Hocaoglu M, Sayman Muslubas I, Arf S, Ersoz MG, Uysal O. Functional and anatomical outcomes following surgical management of persistent fetal vasculature: a single- center experience of 44 cases. Graefe’s Arch Clin Exp Ophthalmol. 2018;256(3):495-501.
18. Ozdemir Zeydanli E, Ozdek S, Acar B, Ozdemir HB, Aktas Z, Gurelik G, et al. Surgical outcomes of posterior persistent fetal vasculature syndrome: cases with tent-shaped and closed funnel-shaped retinal detachment. Eye. Published online 2022.
19. Pollard ZF. Persistent hyperplastic primary vitreous: Diagnosis, treatment and results. Trans Am Ophthalmol Soc. 1997;95:487-549.
20. REESE AB. Persistent hyperplastic primary vitreous. Trans Am Acad Ophthalmol Otolaryngol. 1955;59(3):271-295.
21. Kilty LA, Hiles DA. Unilateral posterior lenticonus with persistent hyaloid artery remnant. Am J Ophthalmol. 1993;104- 106.
22. Zeydanlı EÖ, Tefon AB, Atalay HT, Özdek Ş. Pseudo-hyaloidal Stalk in Anterior Persistent Fetal Vasculature: A Report of Two Cases. Turkish J Ophthalmol. 2021;51(6):407-411.
23. Scuderi G, Balestrazzi E, Ranieri G. Destructive and conservative treatment of persistent hyperplastic primary vitreous and retinal dysplasia. Ophthalmologica. 1976;172(4):346- 352.
24. Hunt A, Rowe N, Lam A, Martin F. Outcomes in persistent hyperplastic primary vitreous. Br J Ophthalmol. 2005;89(7):859-863.
25. Sisk RA, Berrocal AM, Feuer WJ, Murray TG. Visual and anatomic outcomes with or without surgery in persistent fetal vasculature. Ophthalmology. 2010; 117(11).
26. Bosjolie A, Ferrone P. Visual outcome in early vitrectomy for posterior persistent fetal vasculature associated with traction retinal detachment. Retina. 2015;35(3):570-576.
27. Walsh MK, Drenser KA, Capone A, Trese MT. Early vitrectomy effective for bilateral combined anterior and posterior persistent fetal vasculature syndrome. In: Retina. Vol 30.; 2010: S2-S8.
28. Anteby I, Cohen E, Karshai I, BenEzra D. Unilateral persistent hyperplastic primary vitreous: Course and outcome. J AAPOS. 2002;6(2):92-99. doi:10.1067/mpa.2002.121324
29. Stark WJ, Lindsey PS, Fagadau WR, Michels RG. Persistent Hyperplastic Primary Vitreous: Surgical Treatment. Ophthalmology. 1983;90(5):452-457.
30. Alexandrakis G, Scott IU, Flynn HW, Murray TG, Feuer WJ. Visual acuity outcomes with and without surgery in patients with persistent fetal vasculature. Ophthalmology. 2000;107(6): 1068-1072.
31. Warren N, Trivedi RH, Wilson ME. Persistent Fetal Vasculature With Elongated Ciliary Processes in Children. Am J Ophthalmol. Published online 2019;198:25-29.
32. Ozdemir Zeydanli E, Ozdek S, Acar B, Ozdemir HB, Aktas Z, Gurelik G, et al. Surgical outcomes of posterior persistent fetal vasculature syndrome: cases with tent-shaped and closed funnel-shaped retinal detachment. Eye (Lond). 2022 Jun 23. doi: 10.1038/s41433-022-02140-0. Epub ahead of print.

APA	OZDEK S, OZDEMIR ZEYDANLI E (2023). Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz. , 174 - 180. 10.37783/CRJ-0358
Chicago	OZDEK SENGÜL,OZDEMIR ZEYDANLI ECE Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz. (2023): 174 - 180. 10.37783/CRJ-0358
MLA	OZDEK SENGÜL,OZDEMIR ZEYDANLI ECE Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz. , 2023, ss.174 - 180. 10.37783/CRJ-0358
AMA	OZDEK S,OZDEMIR ZEYDANLI E Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz. . 2023; 174 - 180. 10.37783/CRJ-0358
Vancouver	OZDEK S,OZDEMIR ZEYDANLI E Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz. . 2023; 174 - 180. 10.37783/CRJ-0358
IEEE	OZDEK S,OZDEMIR ZEYDANLI E "Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz." , ss.174 - 180, 2023. 10.37783/CRJ-0358
ISNAD	OZDEK, SENGÜL - OZDEMIR ZEYDANLI, ECE. "Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz". (2023), 174-180. https://doi.org/10.37783/CRJ-0358

APA	OZDEK S, OZDEMIR ZEYDANLI E (2023). Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz. Güncel Retina Dergisi, 7(3), 174 - 180. 10.37783/CRJ-0358
Chicago	OZDEK SENGÜL,OZDEMIR ZEYDANLI ECE Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz. Güncel Retina Dergisi 7, no.3 (2023): 174 - 180. 10.37783/CRJ-0358
MLA	OZDEK SENGÜL,OZDEMIR ZEYDANLI ECE Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz. Güncel Retina Dergisi, vol.7, no.3, 2023, ss.174 - 180. 10.37783/CRJ-0358
AMA	OZDEK S,OZDEMIR ZEYDANLI E Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz. Güncel Retina Dergisi. 2023; 7(3): 174 - 180. 10.37783/CRJ-0358
Vancouver	OZDEK S,OZDEMIR ZEYDANLI E Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz. Güncel Retina Dergisi. 2023; 7(3): 174 - 180. 10.37783/CRJ-0358
IEEE	OZDEK S,OZDEMIR ZEYDANLI E "Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz." Güncel Retina Dergisi, 7, ss.174 - 180, 2023. 10.37783/CRJ-0358
ISNAD	OZDEK, SENGÜL - OZDEMIR ZEYDANLI, ECE. "Persistan Fetal Damar Sendromu: Patogenez, Tanı, Tedavi ve Prognoz". Güncel Retina Dergisi 7/3 (2023), 174-180. https://doi.org/10.37783/CRJ-0358